Total T3 Chemiluminescence Assay
by Nichols Institute Diagnostics 510(k)
Active
510(k) K923015
Overview
The Total T3 Chemiluminescence Assay is a radioimmunoassay device used for the measurement of total triiodothyronine in clinical samples. It is designed to assist in the assessment of thyroid function by quantifying the levels of this specific hormone.
This device has received FDA 510(k) clearance under the product code CDP. It is intended for use within a clinical chemistry setting for diagnostic testing purposes.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK923015 | Date2 Sep 1992 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- CDP
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1710
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Other devices from Quest Diagnostics Nichols Institute
Questions
What is the primary purpose of the Total T3 Chemiluminescence Assay?
This device is a radioimmunoassay designed for the measurement of total triiodothyronine in clinical samples. It is used by clinicians to assist in the assessment of thyroid function by quantifying hormone levels.
In what environment is this assay intended to be used?
The assay is intended for use within a clinical chemistry setting. It is designed for diagnostic testing purposes to support clinical evaluations of thyroid health.
Has this device received regulatory authorization?
Yes, the Total T3 Chemiluminescence Assay has received FDA 510(k) clearance. It is classified under product code CDP and regulation number 862.1710 for its use as a radioimmunoassay for total triiodothyronine.